# Wealthing VC Club

> Wealthing VC Club is a VC fund in Palo Alto backing Software and Health Care. See 69 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Palo Alto, United States
- Total investments: 69
- Last investment: Mar 2026
- Lead investor: 0%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/wealthing-vc-club/
- Website: https://wealthing.vc

Wealthing VC Club is a VC fund in Palo Alto focused on Software and Health Care. WVCC is a group of accredited investors who co-invest alongside VCs or angel groups in the US.

## Contacts

5 contacts available for Wealthing VC Club. Shizune tracks 2 team members at Wealthing VC Club. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/wealthing-vc-club?utm_source=investor_profile

## Round sizes

| Stage | Round size |
| --- | --- |
| Series A | $4M–$30M |
| Series B | $10M–$100M |

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Software | 11 | 16% |
| Health Care | 10 | 14% |
| Medical Device | 9 | 13% |
| Biotechnology | 7 | 10% |
| E-Commerce | 6 | 9% |

94 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series B | 12 | 17% |
| Series A | 10 | 14% |
| Convertible Note | 9 | 13% |
| Venture - Series Unknown | 7 | 10% |
| Seed | 4 | 6% |

10 stages tracked in total.

### Country

| Country | Investments | Share |
| --- | --- | --- |
| United States | 38 | 55% |
| India | 1 | 1% |
| Sweden | 1 | 1% |
| Germany | 1 | 1% |
| El Salvador | 1 | 1% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Alicia Castillo Holley | CEO, Founder | 0 | https://shizune.co/investors/profile/alicia-castillo-holley |
| Daniel Chapellin Castillo | COO | 0 | https://shizune.co/investors/profile/daniel-chapellin-castillo |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Nopalera | Nopalera creates Mexican botanical products such as moisturizers, soaps, cleansing creams, and other related products for baths and body that celebrate and elevate Latino culture. | $4M | Series A | Mar 24, 2026 |  |
| Sinaptica Therapeutics | Sinaptica Therapeutics is focused on the development of innovative neuromodulation therapies for Alzheimer's Disease. Their flagship technology, the SinaptiStim™ System, represents a personalized approach to treatment, utilizing closed-loop neuromodulation to enhance cognitive functions. This technology is designed to deliver precisionelectromagnetic therapy, targeting specific neural pathways to improve the symptoms associated with Alzheimer's. Currently, the SinaptiStim™ System is for investigational use and has not received approval for clinical use. Sinaptica Therapeutics is actively engaged in research and development to demonstrate the efficacy and safety of their system, aiming to revolutionize the treatment landscape for Alzheimer's Disease. |  | Convertible Note | Jun 03, 2025 |  |
| FJOR | Fjor Founders Fund is a Los Angeles–based early-stage venture capital firm backing outlier enterprise AI and B2B fintech founders. |  |  | May 13, 2025 |  |
| Embr Labs | Embr Labs is the first thermal wellness technology company that has harnessed the body’s natural response to temperature to enhance human wellbeing. Embr technology leverages temperature as a new pathway to the brain to balance the autonomic nervous system and helps individuals manage hot flashes, sleep disturbances, and anxiety. Embr Labs has tensof thousands of customers in 170 countries. Our customers have logged over 100M minutes and 6M sessions of thermal interventions. A mobile app and cloud infrastructure augment our wearable, forming a unique technology platform that combines thermal stimulation, digital interventions, and data to manage symptoms and treat disease. The technology was invented by the company’s founders while they were engineering students MIT. Embr Labs is backed by DigiTx Partners, Safar Partners, Joy Ventures, Bose Ventures, Intel Capital and others, and been awarded over $2.5M in grant funding from the NIH, DOD, and Massachusetts Life Sciences Center. |  | Venture - Series Unknown | Apr 01, 2025 |  |
| DermaSensor | DermaSensor’s mission is to save lives and healthcare costs by providing easy access to effective skin cancer evaluation, given that the majority of Americans report never having been checked for skin cancer. The DermaSensor device is an affordable, handheld tool that uses machine learning and spectroscopy to objectively evaluate skin lesions forpotential cancer in seconds. |  | Venture - Series Unknown | Mar 16, 2025 |  |
| Lynk Global | Lynk is a mobile connectivity company that allows to partner with mobile network operators to connect existing mobile phone customers to each other, anywhere on the planet. It aims to provide broadband connectivity directly to ordinary mobile phones. Lynk was founded in 2016 and is headquartered in Falls Church, Virginia. | $85M | Series B | Feb 11, 2025 |  |
| NANOCHON | Nanochon is a biotech and medical device company specializing in the development of innovative orthopedic solutions. The company develops medical implant technology focused on cartilage repair for patients with joint surface damage. Its primary product, Chondrograft, is a 3D-printed, synthetic implant engineered to replace lost or damaged cartilageand support the body’s own tissue repair. The design uses a nylon-based composite with structural properties intended to mimic natural cartilage and fit securely into defects using a press-fit surgical procedure. Nanochon’s solution targets individuals who require more than temporary relief but are not yet candidates for total joint replacement, offering an off-the-shelf device that integrates with the healing process. The company’s work includes advancing clinical evaluation and surgical use of its implant technology. |  | Convertible Note | Jan 01, 2025 |  |
| Wavely Diagnostics | Wavely Diagnostics is pioneering the future of remote digital diagnostics and enabling telehealth growth by leveraging smartphone technology to address pediatric care. |  | Convertible Note | Nov 01, 2024 |  |
| Databento | Databento eliminates tens of thousands in upfront data expenses per dataset, while giving you the instant flexibility to pick up real-time full exchange feeds or terabytes of historical data when you need it.Whether you're a Fortune 500 bank or a single-person startup, we scale with your budget and needs and deliver the same cutting edgeperformance and data integrity. |  | Series A | Oct 01, 2024 |  |
| Invasive Species Corporation | ISC creates products to control non-native plants, animals, and other living organisms that threaten the ecosystem (economic or environmental). |  | Convertible Note | Oct 01, 2024 |  |

10 of 69 investments shown.

## Co-investors
- [Sand Hill Angels](https://shizune.co/investors/profile/sand-hill-angels) — VC Fund, 15 deals together
- [Gaingels](https://shizune.co/investors/profile/gaing) — VC Fund, 7 deals together
- [GPO Fund](https://shizune.co/investors/profile/gpo-fund) — VC Fund, 5 deals together
- [HealthTech Capital](https://shizune.co/investors/profile/healthtech-capital) — VC Fund, 5 deals together
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund, 4 deals together
- [WXR Fund](https://shizune.co/investors/profile/women-in-xr) — VC Fund, 4 deals together

## Similar investors

### Similar industry
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund
- [ARCH Venture Partners](https://shizune.co/investors/profile/arch-venture-partners) — VC Fund
- [OrbiMed](https://shizune.co/investors/profile/orbimed-advisors) — VC Fund

### Similar stage
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund
- [FJ Labs](https://shizune.co/investors/profile/fj-labs) — VC Fund

### Similar country
- [Caricaco VC](https://shizune.co/investors/profile/caricaco-vc) — VC Fund
- [Innogen Capital](https://shizune.co/investors/profile/innogen-capital) — VC Fund
- [Bridge Latam](https://shizune.co/investors/profile/bridge-ba20) — VC Fund

## Featured in investor lists
- [All Investors in El Salvador](https://shizune.co/investors/investors-el-salvador)
- [All VC Funds in El Salvador](https://shizune.co/investors/vc-funds-el-salvador)
- [Medical Device VC Funds in LATAM](https://shizune.co/investors/medical-device-vc-funds-latam)
- [Organic Food VC Funds in United States](https://shizune.co/investors/organic-food-vc-funds-united-states)
- [Organic Food Investors in United States](https://shizune.co/investors/organic-food-investors-united-states)
- [Manufacturing Investors in LATAM](https://shizune.co/investors/manufacturing-investors-latam)

## FAQ

### What does Wealthing VC Club invest in?

Wealthing VC Club invests primarily in Software, Health Care and Medical Device startups, most often at Series B and Series A stage. Most of the 69 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### What is Wealthing VC Club's check size?

Wealthing VC Club typically joins rounds of $4M–$30M at Series A and $10M–$100M at Series B. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Wealthing VC Club participates in.

### How do I contact Wealthing VC Club?

Public channels for Wealthing VC Club include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at Wealthing VC Club?

The team at Wealthing VC Club includes Alicia Castillo Holley (CEO, Founder) and Daniel Chapellin Castillo (COO). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co